Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas
RAJ, K. P, ZELL, J. A, ROCK, C. L, MCLAREN, C. E, ZOUMAS-MORSE, C, GERNER, E. W, MEYSKENS, F. L
Published in British journal of cancer (19.02.2013)
Published in British journal of cancer (19.02.2013)
Get full text
Journal Article
Ornithine Decarboxylase-1 Polymorphism, Chemoprevention With Eflornithine and Sulindac, and Outcomes Among Colorectal Adenoma Patients
Zell, Jason A., McLaren, Christine E., Chen, Wen-Pin, Thompson, Patricia A., Gerner, Eugene W., Meyskens, Frank L.
Published in JNCI : Journal of the National Cancer Institute (06.10.2010)
Published in JNCI : Journal of the National Cancer Institute (06.10.2010)
Get full text
Journal Article
Role of obesity in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas
Lin, B. S., Zell, J. A., Madson, N., McLaren, C. E., Gerner, E. W., Meyskens, F. L.
Published in Journal of clinical oncology (01.02.2011)
Published in Journal of clinical oncology (01.02.2011)
Get full text
Journal Article
Use of tumor site as a prognosticator: Population-based analysis of rectosigmoid and rectum cancers
Raj, K. P., Ziogas, A., Barleben, A. R., Stamos, M. J., Zell, J. A.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Role of dietary polyamines in a phase III clinical trial of DFMO and sulindac for prevention of metachronous colorectal adenomas
Raj, K. P., Zell, J. A., Rock, C. L., McLaren, C. E., Zoumas-Morse, C., Gerner, E. W., Meyskens, F. L.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Ornithine decarboxylase ( Odc )-1 gene polymorphism effects on baseline tissue polyamine levels and adenoma recurrence in a randomized phase III adenoma prevention trial of DFMO + sulindac versus placebo
Zell, J. A., McLaren, C. E., Gerner, E. W., Meyskens, F. L.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Pediatric and AYA invasive cutaneous melanoma: Population-based study comparing adult melanoma cases
Cinar, P., Zell, J. A., Taylor, T. H., Sender, L. S., Anton-Culver, H.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Mortality risk for stage I NSCLC with poor histologic grade, tumor size ≥4 cm, and non-upper lobe tumor location: An epidemiologic study of 19,702 patients in the California Cancer Registry from 1989 to 2003
Ou, S. I., Zell, J. A., Ziogas, A., Anton-Culver, H.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article